📰 ReutersReutersCodex · 实盘不做把握 6/10
北京时间·🕒 发布 07-24 23:09:20时区推断·⟳ 抓取 07-24 23:10:55·⚡ 决策 07-25 12:24:45 +13h13m·94.3 天前
GE HealthCare CFO将离任并披露二季度初步增长、重申全年指引
公司预计二季度收入同比增长5.7%、有机增长3.5%，稀释及调整EPS高于此前预期，并重申全年2026指引。
📄 原文Reuters↗ 原文
GE HealthCare's (GEHC.O) Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity out…
不做 GE HealthCare（GEHC.US）
二季度预披露偏正面但只重申全年指引，CFO离任带来治理噪音，且缺少相对一致预期的可量化超预期幅度；等7月29日完整财报后再判断。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 公司宣布Jay Saccaro将卸任CFO，George Newcomb任临时CFO，并披露二季度收入增长5.7%、有机增长3.5%、EPS高于此前预期。
- Reuters报道CFO离任、二季度初步结果和全年指引重申。
关键理由
- 公司预计二季度收入同比增长5.7%、有机增长3.5%，稀释及调整EPS高于此前预期，并重申全年2026指引。
- CFO离任由现任Controller兼CAO临时接任，属于治理与执行不确定性，但公司称交接延续到8月14日。
主要风险
- 完整二季报将在2026-07-29披露，初步数据不是完整财务报表；此前一季度已因通胀、运费和关税压力下调全年利润预期。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-04-29 · 影响 weakens
公司此前已下调全年利润预期，本次只是重申该指引，降低追多吸引力。
检索:GE HealthCare first quarter 2026 lowered profit forecast tariff inflation freight memory chip costs 原文 ↗
原文全文
展开原文 · 1,601 字
GE HealthCare's (GEHC.O) Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity outside the medical technology industry, the company said on Thursday, and also reported preliminary second-quarter results.
The medical device maker named its current controller and chief accounting officer George Newcomb as interim CFO while it looks for a permanent replacement. Saccaro will remain with the company through August 14 to help with the handover.
Finance leadership reshuffles are taking place across the broader healthcare industry. Pfizer (PFE.N) named an interim finance chief in June after Dave Denton announced his departure, and Baxter International (BAX.N) appointed an interim CFO in March following Joel Grade's exit.
GE HealthCare said it expects second-quarter revenue to increase 5.7% from a year earlier, or 3.5% on an organic basis, while it reaffirmed its full-year forecast.
Quarterly diluted and adjusted earnings are expected to come in higher than a year ago and above what the company had forecast earlier, GE HealthCare said.
The Chicago-based firm previously lowered its full-year profit forecast when it reported first-quarter results, citing persistent inflation in memory-chip, oil and freight costs as well as tariff-related pressures stemming from the Middle East conflict.
Newcomb brings more than three decades of finance experience to the interim role, the company said. He has been its controller since 2016 and took on the chief accounting officer position when the firm spun off from General Electric in 2023.
The medical device maker named its current controller and chief accounting officer George Newcomb as interim CFO while it looks for a permanent replacement. Saccaro will remain with the company through August 14 to help with the handover.
Finance leadership reshuffles are taking place across the broader healthcare industry. Pfizer (PFE.N) named an interim finance chief in June after Dave Denton announced his departure, and Baxter International (BAX.N) appointed an interim CFO in March following Joel Grade's exit.
GE HealthCare said it expects second-quarter revenue to increase 5.7% from a year earlier, or 3.5% on an organic basis, while it reaffirmed its full-year forecast.
Quarterly diluted and adjusted earnings are expected to come in higher than a year ago and above what the company had forecast earlier, GE HealthCare said.
The Chicago-based firm previously lowered its full-year profit forecast when it reported first-quarter results, citing persistent inflation in memory-chip, oil and freight costs as well as tariff-related pressures stemming from the Middle East conflict.
Newcomb brings more than three decades of finance experience to the interim role, the company said. He has been its controller since 2016 and took on the chief accounting officer position when the firm spun off from General Electric in 2023.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。